8-(4 (4-phenylbutoxy)benzoyl)amino-2-(tetrazol-5'-yl)-4-oxo-4H-1-benzopyran,
ONO 1078,
ONO-1078,
ONO-RS 411,
ONO-RS-411,
pranlukast,
SB 205312,
Pranlukast,
103177-37-3,
Ono-1078,
pranlukast hydrate,
Onon,
UNII-TB8Z891092,
N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide,
CHEMBL21333,
Azlaire,
NBQKINXMPLXUET-UHFFFAOYSA-N,
Ono-RS-411,
4-Oxo-8-(4-(4-phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl)-4H-1-benzopyran,
TB8Z891092,
150821-03-7,
NCGC00181765-01,
N-(4-OXO-2-(1H-TETRAZOL-5-YL)-4H-CHROMEN-8-YL)-4-(4-PHENYLBUTOXY)BENZAMIDE,
8-[4(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran;8-[4(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran,
N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-P-(4-phenylbutoxy)benzamide;N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-P-(4-phenylbutoxy)benzamide,
Pranlukast (INN),
Azlaire (TN),
Pranlukast [INN:BAN],
SR-05000001474,
SB-205312,
N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenylbutoxy)benzamide,
CCN 00401,
8-[4(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran,
N-[4-oxo-2-(2H-tetrazol-5-yl)-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide,
AC1L1J6B,
SCHEMBL3693,
DSSTox_CID_23782,
DSSTox_RID_80074,
DSSTox_GSID_43782,
MLS006010078,
GTPL3634,
ONO RS-411,
DTXSID3043782,
SCHEMBL18058592,
CHEBI:94810,
CTK7F7297,
KS-00000YQJ,
HMS2089H16,
HMS3650A14,
HMS3714E03,
BCP04577,
HY-B0290,
ZINC1542146,
Tox21_112952,
AC-696,
BDBM50023198,
GP8160,
MFCD00864631,
MFCD24539454,
AKOS015967342,
103177-37-3 (anhyd.),
API0009100,
CCG-220661,
CS-2304,
DB01411,
SB19080,
AK481332,
AN-15615,
AS-15105,
BC220515,
O046,
SC-15917,
SMR004701229,
AB2000316,
LS-194954,
LS-194966,
CAS-103177-37-3,
FT-0652673,
P2115,
A11908,
D08408,
K-0349,
AB01275471-01,
177P373,
L013134,
SR-05000001474-1,
SR-05000001474-2,
SR-05000001474-3,
BRD-K97045029-001-01-9,
BRD-K97045029-001-04-3,
8-[4-(4-phenylbutyloxy)benzoyl]amino-2-(tetrazol-5-yl)-4-oxo-4H-1-benzopyran,
N-(4-oxo-2-(2H-tetrazol-5-yl)-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamide,
N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4(4-phenylbutoxy)benzamide,
N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenyl-butoxy)-benzamide,
N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenyl-butoxy)-benzamide (ONO-RS-411),
N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenyl-butoxy)-benzamide(ONO-RS-411),
null,
ONO 1078,
Pranlukast [BAN:INN],
ONO-RS 411,
D08QIP,
UNII-FR702N558K,
C27H23N5O4,
CID4887,
RS 411,
SB 205312,
C27-H23-N5-O4,
C27H23N5O4.1/2H2O,
B2009,
C047681,
n-[4-oxo-2-(1h-tetrazol-5-yl)-4h-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide,
8-(4 (4-phenylbutoxy)benzoyl)amino-2-(tetrazol-5'-yl)-4-oxo-4H-1-benzopyran,
8-[4-(4-phenylbutoxy)benzamido]-2-(tetrazol-5-yl)-4H-1-benzopy-ran-4-one,
Benzamide, N-(4-oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-4-(4-phenylbutoxy)-,
N-(4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-4-(4-phenylbutoxy)benzamide,
N-(4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-p-(4-phenylbutoxy)benzamide,
N-[4-oxo-2-(2H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)-benzamide,
N-{4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide,
Benzamide, N-(4-oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-4-(4-phenylbutoxy)-, hydrate (2:1),